AstraZeneca on hunt for oncology, cardiovascular acquisitions

AstraZeneca is interested in acquiring small and mid-sized companies specialising in oncology and cardiovascular treatments, Chief Executive Pascal Soriot said in a Reuters Newsmaker interview on Tuesday.

"We always look for external opportunities," he said.

Also Read: FTSE 100 ends higher as AstraZeneca offsets commodity losses